Table 3 Military retention and deployment rates in active duty pilots diagnosed with atrial fibrillation comparing medical and ablative treatment strategies
All (n = 27) | Retained (n = 25) | Discharged (n = 2) | Deployed (n = 12) | Non-deployed (n = 15) | |
|---|---|---|---|---|---|
Medical therapies for AF | |||||
No medical therapy | 5 (19%) | 5 (20%) | 0 (0%) | 5 (42%) | 0 (0%) |
Rate control agent | 11 (41%) | 9 (36%) | 2 (100%) | 4 (33%) | 7 (47%) |
Rhythm control agent | 11 (41%) | 11 (44%) | 0 (0%) | 3 (25%) | 8 (53%) |
Rates of PVI for AF | |||||
No PVI | 11 (41%) | 10 (40%) | 1 (50%) | 6 (50%) | 5 (33%) |
PVI | 16 (59%) | 15 (60%) | 1 (50%) | 6 (50%) | 10 (67%) |
Anticoagulation management for AF | |||||
No anticoagulation | 11 (41%) | 11 (44%) | 0 (0%) | 6 (50%) | 5 (33%) |
Warfarin | 11 (41%) | 10 (40%) | 1 (50%) | 5 (42%) | 6 (40%) |
Direct oral anticoagulants | 5 (19%) | 4 (16%) | 1 (50%) | 1 (8%) | 4 (27%) |